Telomir Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,134 | -1,099 | -5,068 | -2,179 |
EBIT | -5,069 | -2,188 | ||
Net Income | -2,061 | -1,102 | -5,069 | -2,179 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,201 | -927 | -696 | -863 |
Cash | 7,286 | 7,329 | 754 | 402 |
Basic Shares | 34,380 | 31,039 | 30,010 | 29,762 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,942 | |||
EBITDA | -10,538 | 48 | -11,428 | -854 |
EBIT | -12,194 | -3,942 | -1,708 | |
Net Income | -10,413 | -16,532 | -13,071 | -854 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,688 | -5,070 | -3,859 | -468 |
Cash | 7,286 | 1,266 | 1 | 1 |
Basic Shares | 31,653 | 29,539 | 29,609 | 29,609 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.06 |
2025-09-30 | -$0.03 |
2025-06-30 | -$0.17 |
2025-03-31 | -$0.07 |